Antioxidants and polyunsaturated fatty acids in multiple sclerosis.
about
Role of platelets in neuroinflammation: a wide-angle perspectiveTriterpenoid modulation of IL-17 and Nrf-2 expression ameliorates neuroinflammation and promotes remyelination in autoimmune encephalomyelitisFollow-up of multiple sclerosis patients treated with Endotherapia (GEMSP).Uses of complementary and alternative medicine in multiple sclerosisSphingolipids in multiple sclerosis.The influence of nutritional factors on the prognosis of multiple sclerosis.Growth inhibitory effect of polyunsaturated fatty acids (PUFAs) on colon cancer cells via their growth inhibitory metabolites and fatty acid composition changes.Nigella sativa amliorates inflammation and demyelination in the experimental autoimmune encephalomyelitis-induced Wistar ratsA novel oral nutraceutical formula of omega-3 and omega-6 fatty acids with vitamins (PLP10) in relapsing remitting multiple sclerosis: a randomised, double-blind, placebo-controlled proof-of-concept clinical trial.Examining the evidence: complementary adjunctive therapies for multiple sclerosis.Antioxidant therapy in multiple sclerosis.Dietary pattern and risk of multiple sclerosis.Erythrocyte membrane fatty acids in multiple sclerosis patients and hot-nature dietary intervention with co-supplemented hemp-seed and evening-primrose oilsNeuromuscular electrical stimulation and dietary interventions to reduce oxidative stress in a secondary progressive multiple sclerosis patient leads to marked gains in function: a case report.The complex world of oligodendroglial differentiation inhibitors.Oxidative Stress and Neurobiology of Demyelination.Oligodendrocytes: Functioning in a Delicate Balance Between High Metabolic Requirements and Oxidative Damage.GEMSP exerts a myelin-protecting role in the rat optic nerve.Oral administration of the nitroxide radical TEMPOL exhibits immunomodulatory and therapeutic properties in multiple sclerosis models.Topical Metal Chelation Therapy Ameliorates Oxidation-Induced Toxicity in Diabetic CataractEndogenous versus exogenous fatty acid availability affects lysosomal acidity and MHC class II expression
P2860
Q28393808-5CFA2B47-7C76-43F4-BC2F-4FA3CE1B0251Q28394921-06998829-8170-4A0F-8C93-D2C9A50C1FC2Q33599353-4334983E-3BBC-464D-9F43-D80A79650A39Q34080792-09220FE0-BE4C-4232-8639-299C9BADA57BQ34329492-179FCFE9-8124-42A5-B0B5-113EA04B046FQ34643392-7F931721-610D-4EA7-BAC6-AC9527292140Q35606701-ABEB605F-F4FB-48A4-80A8-1C8705EC8DD8Q35918951-1C21D41F-0333-4AF0-B312-5CCB9DA8FC53Q36810081-8D093DCB-D8F0-4973-9821-BAD4B53D56B4Q37217845-B49496A9-E834-446F-B458-4A9DA1F080EDQ37258404-FA0F8D6E-98B2-40E5-825A-BC96A478A275Q37311623-383132DC-8536-46EA-BD07-4715B8609EFBQ37357191-FFEEC0CE-08DD-43E8-B9B1-3DE6F810D017Q37403476-7737438D-C5E5-460B-AFC3-704F0F639077Q37869047-6A3F636E-8559-484A-AC84-5F931518EE51Q38287176-38E7E536-1BA3-4D23-B99D-FD4F3265FFFDQ38974735-2E8C5591-474F-4B3F-8DCB-A912D8D2C002Q44817678-416C167B-EFAF-4DCA-A591-3F892EBACD3FQ46412279-C74EA87C-BE0A-475A-BD90-2D4427E2D6FAQ56948570-A40755DF-A041-4399-9EF3-1912F42F1BB9Q57375107-A06237CA-0CC4-4F59-8923-3F9A04CC6244
P2860
Antioxidants and polyunsaturated fatty acids in multiple sclerosis.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Antioxidants and polyunsaturated fatty acids in multiple sclerosis.
@ast
Antioxidants and polyunsaturated fatty acids in multiple sclerosis.
@en
type
label
Antioxidants and polyunsaturated fatty acids in multiple sclerosis.
@ast
Antioxidants and polyunsaturated fatty acids in multiple sclerosis.
@en
prefLabel
Antioxidants and polyunsaturated fatty acids in multiple sclerosis.
@ast
Antioxidants and polyunsaturated fatty acids in multiple sclerosis.
@en
P2093
P2860
P356
P1476
Antioxidants and polyunsaturated fatty acids in multiple sclerosis.
@en
P2093
Dijkstra CD
Teunissen CE
van Meeteren ME
van Tol EA
P2860
P2888
P304
P356
10.1038/SJ.EJCN.1602255
P577
2005-12-01T00:00:00Z